A PCP's Guide to Dyslipidemia
Current Recommendations ACC/AHA Cholesterol Guidelines/Risk stratification
Risk Calculators
New Options The PCSK9 Variant Story
Patient Follow-Up
PCSK9 Inhibitors 2 Key Indications
PCSK9 Inhibitors Effects on LDL-C and CV Events
Does Reduction in LDL Cholesterol Equal Less Cardiovascular Events Does Reduction in LDL Cholesterol Equal Less Cardiovascular Events? IMPROVE-IT
Case Discussion Understanding FH
Case: Patient Failed to Attain Lipid Goal on Statin Monotherapy
Pharmacoeconomic Issues
Primary Care Management
Patient/Drug Selection and Insurance Coverage
Consider Cost and Precertification for Highest Risk Patients
Summary
Abbreviations
Abbreviations (cont)